THE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)
NCT03551093
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Ischemic Stroke
Interventions
DEVICE:
ISS SPG stimulation
Sponsor
BrainsGate